TABLE 3.
Test method |
BDQ conc |
% of M. tuberculosis isolates showing susceptibility or resistance (no. of susceptible or resistant isolates/total no. of isolates) |
||
---|---|---|---|---|
Wild type (susceptible) |
Rv0678
(resistant) |
atpE
(resistant) |
||
Agar proportion | 0.25 | 99.8 (426/427) | 85.0 (102/120) | 100.0 (30/30) |
0.5 | 100.0 (427/427) | 45.0 (54/120) | 100.0 (30/30) | |
1 | 100.0 (427/427) | 13.3 (16/120) | 100.0 (30/30) | |
BMD frozen | 0.12 | 98.2 (425/433) | 97.3 (109/112) | 100.0 (27/27) |
0.25 | 99.8 (432/433) | 88.4 (99/112) | 100.0 (27/27) | |
BMD dry | 0.12 | 99.1 (430/434) | 100.0 (120/120) | 100.0 (30/30) |
0.25 | 100.0 (434/434) | 86.7 (104/120) | 100.0 (30/30) | |
MGIT960 | 1 | 99.8 (443/444) | 100.0 (120/120) | 100.0 (30/30) |
2 | 100.0 (444/444) | 66.7 (80/120) | 100.0 (30/30) |
Rows in bold indicate the critical concentration of 0.25 μg/ml using the agar proportion method, BDQ breakpoints of 0.12 μg/ml using the BMD method, and CC of 1 μg/ml using the MGIT960 method. BDQ, bedaquiline; BMD, broth microdilution; CC, critical concentration; MGIT, Mycobacteria Growth Indicator Tube.